SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-001777
Filing Date
2022-02-23
Accepted
2022-02-23 16:08:57
Documents
14
Period of Report
2022-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rcus-20220223.htm   iXBRL 8-K 55362
2 EX-99.1 rcus-ex99_1.htm EX-99.1 278998
3 GRAPHIC img230044022_0.jpg GRAPHIC 57792
  Complete submission text file 0000950170-22-001777.txt   543580

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20220223_pre.xml EX-101.PRE 9583
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20220223_lab.xml EX-101.LAB 12936
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20220223.xsd EX-101.SCH 2492
8 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20220223_htm.xml XML 4529
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 22663595
SIC: 2834 Pharmaceutical Preparations